Topics

HIV - AIDS
Quick start to HIV drug treatment can cut risk of illness, death in half
Quick start to HIV drug treatment can cut risk of illness, death in half

An international clinical trial involving nearly 5,000 people with HIV confirms that treatment with antiretroviral drugs should begin sooner rather than later, the National Institutes of Health announced this week. In fact, the benefits of early therapy were so clear that the study was stopped early so that everyone in the trial could receive the drugs. Participants in the Strategic Timing of AntiRetroviral Treatment, or START, study who initiated treatment when their immune system was still strong were 53% less likely to die or develop a serious illness compared with those who delayed treatment until their immune systems had been weakened by the human immunodeficiency virus. People...

Loading